FDA — authorised 29 October 2004
- Application: NDA021457
- Marketing authorisation holder: TEVA BRANDED PHARM
- Local brand name: PROAIR HFA
- Indication: AEROSOL, METERED — INHALATION
- Status: approved
FDA authorised ProAir® HFA on 29 October 2004
Yes. FDA authorised it on 29 October 2004.
TEVA BRANDED PHARM holds the US marketing authorisation.